Reverse Merger With Tocagen Takes Forte’s Dermatology Ambitions Public

 
• By Joseph Haas
  
SC2002_Financial technology_1013827993_1200.jpg
A reverse merger with troubled Tocagen will enable Forte to go public
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business